XML 130 R101.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity (Deficit) - Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Number of Options      
Options outstanding at beginning of period (in shares) 2.0    
Granted (in shares) 0.0    
Exercised (in shares) (0.1)    
Cancelled (in shares) (0.1)    
Options outstanding at end of period (in shares) 1.8 2.0  
Options exercisable (in shares) 1.8    
Options expected to vest (in shares) 0.1    
Weighted Average Exercise Price (per share)      
Options outstanding at beginning of period (in USD per share) $ 33,590,000    
Granted (in USD per share) 57,670,000    
Exercised (in USD per share) 25,940,000    
Cancelled (in USD per share) 22,690,000    
Options outstanding at end of period (in USD per share) 34,400,000 $ 33,590,000  
Options exercisable at end of period (in usd per share) 34,350,000    
Options expected to vest (in USD per share) $ 37,490,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Options outstanding, Weighted Average Remaining Contract Term (Years) 3 years 6 months 5 years 3 months 18 days  
Options exercisable, Weighted Average Remaining Contractual Term (Years) 3 years 6 months    
Options expected to vest, Weighted Average Remaining Contract Term (years) 7 years 2 months 12 days    
Options outstanding at beginning of period, Aggregate Intrinsic Value $ 68    
Exercised, Aggregate Intrinsic Value 3 $ 7 $ 6
Options outstanding at end of period, Aggregate Intrinsic Value 45 $ 68  
Options exercisable, Aggregate Intrinsic Value 44    
Options expected to vest, Aggregate Intrinsic Value $ 1